Testing contract represents high-volume weekly collection of samples and lab testing for K-12 school children across large parts of the state of Alabama
Vancouver, British Columbia–(Newsfile Corp. – November 29, 2021) – Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D84) (“Bloom“), a global platform for healthcare security, announces it has been awarded a contract for testing in Alabama for K-12 schools for the 2021-22 school year. Onsite sample collection is being managed by Bloom’s team of occupational health professionals. All lab testing is being conducted in Bloom’s facilities with it’s data platform being used to securely manage test results for families.
The testing contract is in partnership with the Alabama Department of Public Health (ADPH), the Alabama State Department of Education (ALSDE) and The University of Alabama at Birmingham (UAB) to offer free and voluntary COVID-19 testing for K-12 students, faculty and staff who are asymptomatic, meaning individuals who do not have obvious symptoms.
As a voluntary program, families across the state have the opportunity for their children to be tested weekly. Bloom is providing an end-to-end operation that enables this to take place in a safe, professional environment, similar to occupational health programs run by Bloom in other parts of the United States.
“Our free and voluntary COVID-19 testing program provides an added layer of protection as a part of the mitigation plans that Alabama’s K-12 districts and schools already have in place,” said Dr. Martha S. Wingate, Principal Investigator of the testing program. “Ultimately, the goal of our program is to help schools and districts keep an eye on case numbers, protecting communities from the ‘silent spread’ of COVID-19, and helping to keep children in the classroom, where we know that learning is best achieved. We are proud to partner with Bloom Health Partners for this initiative.”
“We’re focused on running a safe and efficient health program in Alabama,” said Andrew Morton, CEO of Bloom. “For families in the state that would like their children tested on a weekly basis, our team is deployed at schools large and small to reach all parts of the districts we serve. Our experience in occupational health is a base-line for a successful testing program with minimal impact to daily operations in schools.”
About Bloom Health Partners Inc.
Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FRA: D84) is a global platform for healthcare security, diagnostic testing and occupational health-tech. Our mission is to ensure that “unstoppable is possible” for businesses and their employees through innovative, customized healthcare models. Bloom offers a system for businesses and organizations that helps engage employees and creates strategies to manage health and safety. Our stable, scalable system is an integrated health-tech platform that securely manages data while delivering comprehensive workplace health and safety outcomes.
For more information: investors@bloomhealthpartners.com
On behalf of the board of directors,
Bloom Health Partners Inc.
Andrew Morton, Chief Executive Officer
Forward-Looking Statements
This news release includes forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in the Company’s forward-looking statements include the potential that milestones may not be satisfied, acquisitions may not achieve expected benefits, financing requirements, and the other risk factors described in the Company’s filings with Canadian securities regulators on www.sedar.com. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/105314
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…